Investigating the rules and regulations of the registration process of pharmaceutical products in the Common wealth of Independent States (CIS) in comparison to those in Iran
Abstract
Background: Drug Dossier is a file document submitted based on the requirement of the drug approval process. It is a comprehensive scientific document used to obtained worldwide licensing approval of a drug by diverse health authorities. There are different requirements in different countries for registration of a product. Regulatory agencies require Pharmaceutical Dossiers to gain approval to market drugs. Drug Dossier is a document file which has technical and administrative information. Pharma companies prepare dossier as per CTD / Eu CTD / non-CTD (country specific guideline).
Methods: This dissertation is completely descriptive and it is enough to collect, translate and classify the registration process of the countries under study. Finally, its key steps are compared with Iran's regulations, as well as some guidelines for developing exports in accordance with the regulations of the countries under study.
Results: CIS countries follow their own country specific dossier format. Documentation of Dossier in countries of the CIS countries is different from Iran
References
French Public Health Code (2022) . French Republic. Ministry of Health and Access to Care. Available at : https://sante.gouv.fr/soins-et maladies/medicaments/le-bon-usage des-medicaments/article/qu-est-ce-qu un-medicament. (Accessed: 24 November 2024).
World Health Organisation. (2002). Promoting rational use of medicines : core components. World Health Organisation. Available at : https://iris.who.int/handle/10665/674 38. (Accessed: 24 November 2024).
OECD (2021), Health at a Glance 2021: OECD Indicators, Éditions OCDE, Paris, https://doi.org/10.1787/ae3016 b9-en (Accessed: 23 November 2024).
Gu Q, Dillon CF, Burt VL (2010). Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008. NCHS Data Brief. 2010 Sep;(42):1-8. PMID: 20854747.
Mousnad, M. A., Shafie, A. A., & Ibrahim, M. I. (2014). Systematic review of factors affecting pharmaceutical expenditures. Health Policy (Amsterdam, Netherlands), 116(2‑3), 137‑146. https://doi.org/10.1016/j.healthpol.20 14.03.010
Alkan, Ö., & Elmali, K. (2015). The Determination of the Factors Affecting Pharmaceutical Consumption in Respect to Provinces in Turkey. Mediterranean Journal of Social Sciences. https://doi.org/10.5901/mjss.2015.v6n 6p356
Galès, C. L. (2018). Évolution, déterminants et régulation des dépenses de médicaments en France. médecine/sciences, 34(1). https:/doi.org/10.1051/medsci/201834 01018
Marković-Peković V, Ljubica Bojanić Lj, Stoisavljević-Šatara S.(2019). The characteristics of the outpatient utilisation of medicines in the Republic of Srpska from 2009-2017. Scr Med ;50(4):167-76
Vincent K.C. Yan, Joseph E. Blais, Xue Li, Celine S.L. Chui, Li Wei, Bryan P. Yan, Martin R.J. Knapp, Chung Wah Siu, Ian C.K. Wong, Esther W. Chan. (2021). Trends in Cardiovascular Medicine Use in 65 Middle- and High-Income Countries, JAAmerican College of Cardiology, 77, 7,1021-1023. https://doi.org/10.1016/j.jacc.2020.12. 025
Bouwer, J. C., Govender, S., & Robertson, L. J. (2021). Medicines used in mental, neurological and substance use disorders in Gauteng, South Africa : A secondary analysis of the 2017–2018 provincial pharmaceutical database, Part 1. South African Journal of Psychiatry, 27. https://www.ajol.info/index.php/sajps yc/article/view/241160
Auvray, L., & Sermet, C. (2002). Consommations et prescriptions pharmaceutiques chez les personnes âgées :Un état des lieux. Gérontologie et société, 25103(4), 13‑27. https://doi.org/10.3917/gs.103.0013
Shah, R. B., Gajjar, B. M., & Desai, S. V. (2012). Drug utilisation pattern among geriatric patients assessed with the anatomical therapeutic chemical classification/defined daily dose system in a rural tertiary care teaching hospital. International Journal of Nutrition, Pharmacology, Neurological Diseases, 2(3), 258. https://doi.org/10.4103/2231 0738.99480
Gama, H., Torre, C., Guerreiro, J. P., Azevedo, A., Costa, S., & Lunet, N. (2017). Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal. BMC Health Services Research, 17(1), 449. https://doi.org/10.1186/s12913-017 2401-2
Lisauskienė, I., Garuolienė, K., & Gulbinovič, J. (2017). Utilisation of cardiovascular medicines and cardiovascular mortality in Lithuania, Sweden and Norway in 2003–2012. Medicina, 53(4), Article 4. https://doi.org/10.1016/j.medici.2017. 07.004
Kalinić, D., Škrbić, R., Vulić, D., Stojaković, N., Stoisavljević-Šatara, S., Stojiljković, M. P., Marković-Peković, V., Golić Jelić, A., Pilipović-Broćeta, N., Wong, N. D., & Godman, B. (2022). Trends in Antihypertensive Medicine Utilisation in the Republic of Srpska, Bosnia and Herzegovina : An Eleven Year Follow-Up. Pharmacology, Frontiers 13, in 889047. https://doi.org/10.3389/fphar.2022.88 9047
WHO Regional Office for Africa. (2014). The health of the people: what works - the African Regional Health Report 2014. Available at: http://extranet.who.int/iris/restricted/ bitstream/handle/10665/137377/9789 290232612.pdf;jsessionid=9B283B2A9 2CD71D81DF839709FB07A4C?sequenc e=4 (accessed: 5 October 2024).
African Development Bank.. (2022) Human Development. Available at: https://www.afdb.org/en/knowledge/ publications/trackingafrica%E2%80%99 s-progress-in-figures/human development (Accessed: 23 November 2024).
Soussi-Tanani, D., Alaoui, K., Belaiche, A., Hassar, M., & Cherrah, Y. (2008). Analyse de la consommation des antihypertenseurs au Maroc : Période 1991-2005. Therapies, 63(2), 129‑133. https://doi.org/10.2515/therapie:2008 035
Mousnad MA, Ibrahim MIM, Palaian S, Shafie AA. (2017). Medicines utilisation and trends in Sudan between 2006 and 2010. Trop J Pharm Res ; 16(7): 1717.
Ain, M. R., Shahzad, N., Aqil, M., Alam, M. S., & Khanam, R. (2010). Drug utilisation pattern of antibacterials used in ear, nose and throat outpatient and inpatient departments of a university hospital at New Delhi, India. Journal of Pharmacy and Bioallied Sciences, 2(1), 8. https://doi.org/10.4103/0975 7406.62695
Ali, H., Zafar, F., Alam, S., Beg, A. E., Bushra, R., Manzoor, A., Naqvi, G. R., Yasmeen, R., Shafiq, Y., Tariq, A., Zubair, S., & Saleem, S. (2018). Drug utilisation and prescribing pattern of antibiotics in a tertiary care setups; trends and practices. Pak. J. Pharm. Sci. 2018 Mar;31(2(Suppl.)):691-697.
Landstedt, K., Sharma, A., Johansson, F., Lundborg, C. S., & Sharma, M. (2017). Antibiotic prescriptions for inpatients having nonbacterial diagnosis at medicine departments of two private sector hospitals in Madhya Pradesh, India : A cross-sectional study. https://doi.org/10.1136/bmjopen 2016-012974
Rasmussen L, Wettermark B, Steinke D, Pottegård A. Core concepts in pharmacoepidemiology: Measures of drug utilisation based on individual level drug dispensing data. Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1015-1026. doi: 10.1002/pds.5490
Štimac, D., Polić-Vižintin ,Marina, Škes ,Marija, Cattunar ,Albert, Cerović ,Robert, & and Stojanović, D. (2010). Utilisation of cardiovascular drugs in Zagreb 2001-2005. Acta Cardiologica, 65(2), 193‑201. https://doi.org/10.2143/AC.65.2.20470 53
Hollingworth, S. A., Ankrah, D., Uzochukwu, B. S. C., Okeke, C. C., Ruiz, F., & Thacher, E. (2022). Antihypertensive medicine use differs between Ghana and Nigeria. BMC Cardiovascular Disorders, 22(1), 368. https://doi.org/10.1186/s12872-022 02799-z
Agence Nationale de la statistique de Côte d’Ivoire (2021) . Récensement général dela population et de l'habitat 2021. Résultats globaux définitifs. Available at: https://www.ins.ci/RGPH2021/RESULT ATS%20DEFINITIFSRP21.pdf(Accessed: 25 November 2024).
Patel, S., Shah, A., Shah, R., & Buch, J. (2016). Evaluation of drug utilisation pattern of antimicrobials using ATC/DDD system in intensive care unit of a tertiary-care teaching hospital. 18 International Journal of Medical Science and Public Health, 5(1), 80. https://doi.org/10.5455/ijmsph.2016.0 8112015189
